Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate.
paper
Cited
Public
Unavailable
- Authors
- Dahchour, A; De Witte, P
- Year
- 2000
- Journal
- Progress in neurobiology
- PMID
- 10670704
- DOI
- 10.1016/s0301-0082(99)00031-3
Ethanol induces alterations in the central nervous system by differentially interfering with a number of neurotransmitter systems, although the mechanisms by which such effects are executed are not well understood. The present review therefore, is designed to ascertain the effect of ethanol on both excitatory and inhibitory amino acid neurotransmitters, as well as the sulphonated amino acid taurine, assayed by the microdialysis technique within specific brain regions of rat during different types of alcohol intoxication, acute and chronic, as well as during the withdrawal period. Such an understanding of these pharmacological actions of ethanol on neurotransmitters is essential in order to provide the impetus for the development of appropriate therapeutic intervention to ameliorate the multitude of neurochemical disorders induced by ethanol. In addition the possible mode of action of a new therapeutic drug for the treatment of alcoholism, acamprosate will be discussed. The first part of this review will be limited to studies of the effect of ethanol on both amino acid neurotransmitters and the sulphonated amino acid taurine, a possible neuromodulator. While, the second part will seek to establish the possible mechanism of action of a new therapeutic drug, acamprosate, which is used to combat the effects of ethanol, particularly during the craving period, as well as maintaining abstinence in weaned alcoholics.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The effects of sub-chronic calcium treatment on ethanol-induced dopamine elevation and the alcohol deprivation effect in the rat. | Ademar K et al. | — | 2026 | → |
| Current treatments of alcohol use disorder. | Dionisi T et al. | — | 2024 | → |
| Acamprosate reduces ethanol intake in the rat by a combined action of different drug components. | Ademar K et al. | — | 2023 | → |
| Alcohol Consumption and Mild Cognitive Impairment: A Mendelian Randomization Study from Rural China. | Cui Y et al. | — | 2022 | → |
| Sodium acamprosate and calcium exert additive effects on nucleus accumbens dopamine in the rat. | Ademar K et al. | — | 2022 | → |
| The Persistent Challenge of Developing Addiction Pharmacotherapies. | Swinford-Jackson SE et al. | — | 2021 | → |
| Taurine enhances voluntary alcohol intake and promotes anxiolytic-like behaviors in rats. | Pulcinelli RR et al. | — | 2020 | → |
| Ethanol-induced changes in synaptic amino acid neurotransmitter levels in the nucleus accumbens of differentially sensitized mice. | Nashed MG et al. | — | 2019 | → |
| Acute effect of Ethanol and Taurine on frontal cortex absolute beta power before and after exercise. | Paulucio D et al. | — | 2018 | → |
| Generation of silent synapses in dentate gyrus correlates with development of alcohol addiction. | Beroun A et al. | — | 2018 | → |
| Purinergic Signaling in Neuron-Astrocyte Interactions, Circadian Rhythms, and Alcohol Use Disorder. | Lindberg D et al. | — | 2018 | → |
| Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users? | Kleczkowska P et al. | — | 2016 | → |
| Noni (Morinda citrifolia Linn.) fruit juice attenuates the rewarding effect of ethanol in conditioned place preference in mice. | Pandy V et al. | — | 2016 | → |
| Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects. | Nam HW et al. | — | 2015 | → |
| Targeting glutamate uptake to treat alcohol use disorders. | Rao PS et al. | — | 2015 | → |
| The indirect NMDAR antagonist acamprosate induces postischemic neurologic recovery associated with sustained neuroprotection and neuroregeneration. | Doeppner TR et al. | — | 2015 | → |
| The clinical pharmacology of acamprosate. | Kalk NJ et al. | — | 2014 | → |
| The development of acamprosate as a treatment against alcohol relapse. | Kufahl PR et al. | — | 2014 | → |
| Antidepressant effect of aminophylline after ethanol exposure. | Escudeiro SS et al. | — | 2013 | → |
| Differential effects of baclofen and oxytocin on the increased ethanol consumption following chronic psychosocial stress in mice. | Peters S et al. | — | 2013 | → |
| Acamprosate modulates experimental autoimmune encephalomyelitis. | Sternberg Z et al. | — | 2012 | → |
| Behavioral deficits and cellular damage following developmental ethanol exposure in rats are attenuated by CP-101,606, an NMDAR antagonist with unique NR2B specificity. | Lewis B et al. | — | 2012 | → |
| Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1. | Hinton DJ et al. | — | 2012 | → |
| Event-Related Oscillations in Alcoholism Research: A Review. | Pandey AK et al. | — | 2012 | → |
| Rational development of addiction pharmacotherapies: successes, failures, and prospects. | Pierce RC et al. | — | 2012 | → |
| Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1. | Lee MR et al. | — | 2011 | → |
| A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence. | Kampman KM et al. | — | 2011 | → |
| Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence. | Mason BJ et al. | — | 2010 | → |
| Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. | Schmidt HD et al. | — | 2010 | → |
| Intermittent high-dose ethanol exposures increase motivation for operant ethanol self-administration: possible neurochemical mechanism. | Li Z et al. | — | 2010 | → |
| Neuroprotection by taurine in ethanol-induced apoptosis in the developing cerebellum. | Taranukhin AG et al. | — | 2010 | → |
| The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence. | Mason BJ et al. | — | 2010 | → |
| Aminophylline (a theophylline-ethylenediamine complex) blocks ethanol behavioral effects in mice. | Soares PM et al. | — | 2009 | → |
| Association of single nucleotide polymorphisms in a glutamate receptor gene (GRM8) with theta power of event-related oscillations and alcohol dependence. | Chen AC et al. | — | 2009 | → |
| Glycine receptor expression in the forebrain of male AA/ANA rats. | Jonsson S et al. | — | 2009 | → |
| Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence. | Kampman KM et al. | — | 2009 | → |
| Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice. | Farook JM et al. | — | 2008 | → |
| Breath alcohol level and plasma amino acids: a comparison between older and younger chronic alcohol-dependent patients. | Walter H et al. | — | 2008 | → |
| Determination of amino acid levels in the rat striatum, after administration of ethanol alone and associated with ketamine, a glutamatergic antagonist. | Vasconcelos SM et al. | — | 2008 | → |
| Glutamatergic substrates of drug addiction and alcoholism. | Gass JT et al. | — | 2008 | → |
| High temporal resolution of amino acid levels in rat nucleus accumbens during operant ethanol self-administration: involvement of elevated glycine in anticipation. | Li Z et al. | — | 2008 | → |
| Uncovering genes for cognitive (dys)function and predisposition for alcoholism spectrum disorders: a review of human brain oscillations as effective endophenotypes. | Rangaswamy M et al. | — | 2008 | → |
| Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats. | Bowers MS et al. | — | 2007 | → |
| Ethanol and acetaldehyde induce similar changes in extracellular levels of glutamate, taurine and GABA in rat anterior cingulate cortex. | Zuo GC et al. | — | 2007 | → |
| Preclinical and clinical pharmacology of alcohol dependence. | Tambour S et al. | — | 2007 | → |
| Acamprosate: a new tool in the battle against alcohol dependence. | Wright TM et al. | — | 2006 | → |
| Alcohol, neurotransmitter systems, and behavior. | Chastain G | — | 2006 | → |
| Attenuation of cocaine-induced reinstatement of cocaine conditioned place preference by acamprosate. | Mcgeehan AJ et al. | — | 2006 | → |
| Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice. | Escher T et al. | — | 2006 | → |
| Drugs, their targets and the nature and number of drug targets. | Imming P et al. | — | 2006 | → |
| Glutamic acid in withdrawal and weaning in patients classified according to Cloninger's and Lesch's typologies. | Walter H et al. | — | 2006 | → |
| Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse. | Sanchis-Segura C et al. | — | 2006 | → |
| Microdialysis as a tool in local pharmacodynamics. | Li Y et al. | — | 2006 | → |
| Nicotine-induced changes of glutamate and arginine in naive and chronically alcoholized rats: an in vivo microdialysis study. | Lallemand F et al. | — | 2006 | → |
| Recurrent detoxifications are associated with craving in patients classified as type 1 according to Lesch's typology. | Hillemacher T et al. | — | 2006 | → |
| Acamprosate for the treatment of alcohol dependence. | Boothby LA et al. | — | 2005 | → |
| Binge drinking in midlife and dementia risk. | Järvenpää T et al. | — | 2005 | → |
| Differential effects of ethanol ingestion on somatostatin content, somatostatin receptors and adenylyl cyclase activity in the frontoparietal cortex of virgin and parturient rats. | Barrios V et al. | — | 2005 | → |
| Effect of acamprosate on neonatal excitotoxic cortical lesions in in utero alcohol-exposed hamsters. | Adde-Michel C et al. | — | 2005 | → |
| Influence of ethanol on the threshold for electroshock-induced seizures and electrically-evoked hippocampal afterdischarges. | Fischer W | — | 2005 | → |
| Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons. | Maler JM et al. | — | 2005 | → |
| Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. | De Witte P et al. | — | 2005 | → |
| Role of altered structure and function of NMDA receptors in development of alcohol dependence. | Nagy J et al. | — | 2005 | → |
| The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. | Spanagel R et al. | — | 2005 | → |
| The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. | Bachteler D et al. | — | 2005 | → |
| Alcoholism: genes and mechanisms. | Oroszi G et al. | — | 2004 | → |
| Differential increase in taurine levels by low-dose ethanol in the dorsal and ventral striatum revealed by microdialysis with on-line capillary electrophoresis. | Smith A et al. | — | 2004 | → |
| Effect of the combination of naltrexone and acamprosate on alcohol intake in mice. | Kim SG et al. | — | 2004 | → |
| Ethanol modulates neuropeptide-degrading aminopeptidases at synapse level in calcium-dependent conditions. | Mayas MD et al. | — | 2004 | → |
| In vivo monitoring of amino acids by microdialysis sampling with on-line derivatization by naphthalene-2,3-dicarboxyaldehyde and rapid micellar electrokinetic capillary chromatography. | Shou M et al. | — | 2004 | → |
| Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence. | Boeijinga PH et al. | — | 2004 | → |
| Pharmacotherapy of alcohol dependence: a review of the clinical data. | Mann K | — | 2004 | → |
| Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography. | Courtyn J et al. | — | 2004 | → |
| Taurine activates strychnine-sensitive glycine receptors in neurons freshly isolated from nucleus accumbens of young rats. | Jiang Z et al. | — | 2004 | → |
| Colocalization of taurine and glial fibrillary acidic protein immunoreactivity in mouse hippocampus induced by short-term ethanol exposure. | Sakurai T et al. | — | 2003 | → |
| Does acamprosate improve reduction of drinking as well as aiding abstinence? | Chick J et al. | — | 2003 | → |
| Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. | Heyser CJ et al. | — | 2003 | → |
| Future directions in substance dependence research. | Nutt D et al. | — | 2003 | → |
| Neurobiology of addiction and implications for treatment. | Lingford-Hughes A et al. | — | 2003 | → |
| Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. | Littleton J et al. | — | 2003 | → |
| Systemic osmotic manipulations modulate ethanol-induced taurine release: a brain microdialysis study. | Quertemont E et al. | — | 2003 | → |
| The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. | McGeehan AJ et al. | — | 2003 | → |
| Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat. | Mayer S et al. | — | 2002 | → |
| Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. | Harris BR et al. | — | 2002 | → |
| Acamprosate, MK-801, and ifenprodil inhibit neurotoxicity and calcium entry induced by ethanol withdrawal in organotypic slice cultures from neonatal rat hippocampus. | Mayer S et al. | — | 2002 | → |
| Differential taurine responsiveness to ethanol in high- and low-alcohol sensitive rats: a brain microdialysis study. | Quertemont E et al. | — | 2002 | → |
| Effects of acamprosate and some polyamine site ligands of NMDA receptor on short-term memory in rats. | Mikolajczak P et al. | — | 2002 | → |
| Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain. | al Qatari M et al. | — | 2001 | → |
| Behavioral consequences of the hypotaurine-ethanol interaction. | Font L et al. | — | 2001 | → |
| Effects of acamprosate and scopolamine on the working memory of rats in a three-panel runway task. | Okulicz-Kozaryn I et al. | — | 2001 | → |
| Effects of acamprosate on ethanol-seeking and self-administration in the rat. | Czachowski CL et al. | — | 2001 | → |
| Ethanol decreases the expression of mitochondrial cytochrome c oxidase mRNA in the rat. | Kim JH et al. | — | 2001 | → |
| The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. | Rammes G et al. | — | 2001 | → |
| Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders. | Bisaga A et al. | — | 2000 | → |